These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitor.
    Author: Santoro F, Cozzani E, Parodi A.
    Journal: J Dermatolog Treat; 2006; 17(3):160-1. PubMed ID: 16854757.
    Abstract:
    The use of epidermal growth factor receptor (EGFR) inhibitors for the treatment of solid tumours is now increasing. Cutaneous side effects, namely acneiform eruption, xerosis, telangiectasia, hyperpigmentation, fissures, hair and nail changes, are reported in literature. We describe a case of a man treated with an EGFR-inhibitor (erlotinib) for a cell lung cancer who developed skin manifestations localized in an uncommon area and with an atypical evolution.
    [Abstract] [Full Text] [Related] [New Search]